Literature DB >> 29563726

Philosophy on Neck Dissection in Thyroid Cancer-Current Controversies and Consensus.

Benzon M Dy1, Ashok R Shaha1.   

Abstract

Thyroid cancer commonly metastasizes to lymph nodes either in the central compartment or lateral neck in at least 50% of patients. Over the past several decades, our understanding of the natural progression of thyroid cancer has changed. Our current practice reflects our increasingly sophisticated understanding of the biology of thyroid cancer while taking into account the morbidity and mortality associated with aggressive variants of the disease.

Entities:  

Keywords:  Delphian lymph nodes; Dissection; Thyroid cancer

Year:  2017        PMID: 29563726      PMCID: PMC5856702          DOI: 10.1007/s13193-017-0720-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  24 in total

1.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery.

Authors:  K Thomas Robbins; Garry Clayman; Paul A Levine; Jesus Medina; Roy Sessions; Ashok Shaha; Peter Som; Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

2.  Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.

Authors:  Ian D Hay; Robert A Lee; Caroline Davidge-Pitts; Carl C Reading; J William Charboneau
Journal:  Surgery       Date:  2013-10-28       Impact factor: 3.982

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; Marie R Griffin; John E Phay
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

5.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

6.  Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?

Authors:  Raul Alvarado; Mark S Sywak; Leigh Delbridge; Stan B Sidhu
Journal:  Surgery       Date:  2009-03-27       Impact factor: 3.982

7.  Selective lateral compartment neck dissection for thyroid cancer.

Authors:  Kellen Welch; Christopher R McHenry
Journal:  J Surg Res       Date:  2013-05-23       Impact factor: 2.192

8.  Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance.

Authors:  Ralph P Tufano; Gary Clayman; Keith S Heller; William B Inabnet; Electron Kebebew; Ashok Shaha; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

9.  Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Dorothy Thomas; Iain J Nixon; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ashok R Shaha; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

10.  Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study.

Authors:  Sohee Park; Chang-Mo Oh; Hyunsoon Cho; Joo Young Lee; Kyu-Won Jung; Jae Kwan Jun; Young-Joo Won; Hyun-Joo Kong; Kui Son Choi; You Jin Lee; Jin Soo Lee
Journal:  BMJ       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.